Andere talen ProText Mobility, Inc.

Aandelen

TXTM

US74371E2046

Beurs gesloten - OTC Markets Andere beurzen 21:59:54 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0023 ^USD	+27,78%		+27,78%	+35,29%

2022

Protext Mobility, Inc en RSAMMDA LLC geven een update aan de aandeelhouders

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION	14-11-22
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	01-11-22
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	01-11-22
Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	01-11-22
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PROVIDE SHAREHOLDERS UPDATE AND NEAR TERM ROAD MAP	01-08-22
ProText Mobility : Quarterly Report - Protext Q3 2021 - Amended	03-12-21
ProText Mobility : Quarterly Report	21-11-21
ProText Mobility : Notification of Late Filing	16-11-21
PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND	29-10-21
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	29-10-21
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)	07-05-20
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Signs Letter of Intent with USA-based Protext Pharma (TXTM) for Commercialization of Next Generation Live Cannabis and Hemp Extraction Technology	30-04-20
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.	19-01-19
Protext Pharma to Acquire Cannabis Blockchain Company Growprocess, Inc.	19-01-18
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.	19-01-18
Protext Pharma : Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance	20-09-17
Protext Pharma : to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes	13-09-17
Protext Mobility : Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License	23-05-17
ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc	23-05-17
Protext Mobility : Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial	04-05-17

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ProText Mobility, Inc.

Aandelen

TXTM

US74371E2046

Andere talen

Filters